poor response
Showing 26 - 50 of >10,000
Chronic Kidney Diseases, COVID-19 Trial in Scarborough, Toronto (Pfizer-BioNTech COVID-19 Vaccine, MODERNA SARS-CoV-2 Vaccine)
Active, not recruiting
- Chronic Kidney Diseases
- COVID-19
- Pfizer-BioNTech COVID-19 Vaccine
- MODERNA SARS-CoV-2 Vaccine
-
Scarborough, Ontario, Canada
- +2 more
Aug 5, 2022
Moderate and Severe RheumatoId Arthritis Trial in Beijing (Placebo plus MTX, RC18 160 mg plus MTX)
Active, not recruiting
- Moderate and Severe RheumatoId Arthritis
- Placebo plus MTX
- RC18 160 mg plus MTX
-
Beijing, Beijing, ChinaPeking Union Medical College Hospital
Jan 9, 2022
Osteosarcoma, Survival, Chemo Effect Trial in Beijing (MAPI chemo, Apatinib Mesylate, Camrelizumab)
Unknown status
- Osteosarcoma
- +3 more
- MAPI chemotherapy
- +2 more
-
Beijing, ChinaPeking University People's Hospital
May 15, 2020
Premature Ovarian Failure, Diminished Ovarian Reserve Trial in Istanbul (PRP injection into at least one ovary)
Completed
- Premature Ovarian Failure
- Diminished Ovarian Reserve
- PRP injection into at least one ovary
-
Istanbul, TurkeyAcıbadem University
Nov 21, 2020
Obesity Trial in London (Liraglutide Pen Injector [Saxenda], Placebo)
Completed
- Obesity
- Liraglutide Pen Injector [Saxenda]
- Placebo
-
London, United KingdomUCLH
Nov 4, 2020
Poor Ovarian Response Trial in Manama (Femara,Grotwth hormone,HMG)
Unknown status
- Poor Ovarian Response
- Femara,Grotwth hormone,HMG
-
Manama, BahrainAl-BARAKA FERTILITY HOSPITAL
Jul 7, 2020
Breast Cancer Trial in Guangzhou (Pyrotinib)
Not yet recruiting
- Breast Cancer
-
Guangzhou, Guangdong, ChinaSun Yat-sen University Cancer Center
Feb 5, 2020
Osteosarcoma Trial in France (Mifamurtide, EI or M-API regimen depending on patient age)
Recruiting
- Osteosarcoma
- Mifamurtide
- EI or M-API regimen depending on patient age
-
Amiens, France
- +30 more
Dec 8, 2022
Primary Biliary Cholangitis (PBC) Trial in Guangzhou (Probiotic, Placebo)
Unknown status
- Primary Biliary Cholangitis (PBC)
- Probiotic
- Placebo
-
Guangzhou, Guangdong, ChinaThird Affliated Hospital of Sun Yat-sen University
Jan 4, 2020
Rheumatoid Arthritis, Systemic Lupus Erythematosus (SLE), Pemphigus Vulgaris Trial in United States (Moderna mRNA-1273,
Recruiting
- Rheumatoid Arthritis
- +8 more
- Moderna mRNA-1273
- +5 more
-
Los Angeles, California
- +24 more
Aug 17, 2022
Infertility, Female Trial in Giza (Growth hormone/HPuFSH/GnRH antagonist, HPuFSH/GnRH antagonist)
Unknown status
- Infertility, Female
- Growth hormone/HPuFSH/GnRH antagonist
- HPuFSH/GnRH antagonist
-
Giza, EgyptRiyadh Fertility and Reproductive Health center
May 24, 2020
Infertility Trial in Hanoi (Testosterone gel)
Completed
- Infertility
- Testosterone gel
-
Hanoi, VietnamHanoi Medical University, Vietnam
Oct 20, 2020
Primary Biliary Cirrhosis Trial in Guangzhou (total response Group)
Completed
- Primary Biliary Cirrhosis
- total response Group
-
Guangzhou, Guangdong, ChinaThe Third Affiliated Hospital of Sun Yat-sen University
Dec 23, 2019
GH on Outcomes of IVF and Telomerase Activity of Granulosa Cells
Unknown status
- GH
- Poor Ovarian Reserve Based on POSEIDON
- growth hormone
- (no location specified)
May 19, 2020
Migraine With or Without Aura Trial in Worldwide (Placebo, Eletriptan 40 mg, Eletriptan 80 mg)
Completed
- Migraine With or Without Aura
- Placebo
- +2 more
-
Arhus C, Denmark
- +42 more
Jan 26, 2021
Poor Ovarian Response Trial in Beirut (Myo-inositol)
Recruiting
- Poor Ovarian Response
-
Beirut, LebanonAmerican University of Beirut Medical Center
Feb 14, 2020
Complications; Artificial Fertilization, Introduction of Embryo in Embryo Transfer Trial in Barcelona (Somatropin)
Terminated
- Complications; Artificial Fertilization, Introduction of Embryo in Embryo Transfer
-
Barcelona, SpainDepartamento de Obstetricia Ginecologia y Reproducción. Institut
Feb 10, 2020
Quantify Degree of Pain Relief of Pelvic Congestion Syndrome
Recruiting
- Pelvic Congestive Syndrome
- Pelvic Pain
-
Kansas City, KansasThe University of Kansas Medical Center
Nov 1, 2022
Acute Lymphoid Leukemia Trial in Philadelphia (huCART19)
Recruiting
- Acute Lymphoid Leukemia
- huCART19
-
Philadelphia, PennsylvaniaChildren's Hospital of Pennsylvania
Jul 21, 2022
Transfusion-dependent Hemachromatosis, Thalassemia Major, Sickle Cell Disease Trial in Boston (Deferoxamine, Deferasirox, HIDA)
Completed
- Transfusion-dependent Hemachromatosis
- +2 more
- Deferoxamine
- +2 more
-
Boston, MassachusettsChildren's Hospital Boston
Jun 14, 2019
Schizophrenia, Schizoaffective Disorder Trial in Nashville (long-acting injectable risperidone, long acting injectable
Completed
- Schizophrenia
- Schizoaffective Disorder
- long-acting injectable risperidone
- long acting injectable risperidone
-
Nashville, TennesseeVanderbilt Psychiatric Hospital
Jul 17, 2019
Nasopharyngeal Cancer Trial in Shanghai (Toripalimab, Induction chemo and concurrent chemoradiation)
Recruiting
- Nasopharyngeal Cancer
- Toripalimab
- Induction chemotherapy and concurrent chemoradiation
-
Shanghai, Shanghai, ChinaFudan Universtiy Shanghai Cancer Centre
Nov 25, 2022
Poor Ovarian Response, Accupuncture Trial in Tehran (Accupuncture)
Unknown status
- Poor Ovarian Response
- Accupuncture
- Accupuncture
-
Tehran, Iran, Islamic Republic ofRoyan Institute
Jul 6, 2019
Multimodal Ultrasound Imaging Assessment on Keloid
Completed
- Keloid
- multimodal ultrasound
- radioisotope applicator therapy
-
Chongqing, Chongqing, ChinaThe Second Affiliated Hospital of Chongqing Medical University
Sep 12, 2023